What are the treatment options for female androgenetic alopecia (female pattern hair loss)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Female Androgenetic Alopecia

Start with topical minoxidil 5% applied twice daily as first-line therapy, which must be continued indefinitely to maintain results. 1, 2

First-Line Treatment: Topical Minoxidil

  • Minoxidil 5% (1 mL) applied twice daily is the American Academy of Dermatology's recommended first-line treatment for female pattern hair loss. 1
  • This concentration is superior to 2% formulations and must be continued indefinitely, as discontinuation leads to complete reversal of hair growth benefits. 1
  • Meta-analysis confirms minoxidil is effective in women with androgenetic alopecia (P < .00001). 3

Enhanced Treatment: Combination Therapy with PRP

For patients seeking superior results or inadequate response to minoxidil alone, add platelet-rich plasma (PRP) therapy to topical minoxidil 5%. 1, 2

Why Combination Therapy Works Better

  • PRP combined with minoxidil is significantly more effective than minoxidil monotherapy, showing the highest increase in hair density in comparative studies. 1, 4
  • PRP increases hair density by 27.7-45.9/cm² compared to baseline. 2
  • Combined therapy increases hair density 1.74 times and hair diameter 14.3 times compared to baseline. 2
  • PRP induces proliferation of dermal papilla cells, increases vascularization of perifollicular tissue, and accelerates telogen-to-anagen transition. 1

Specific PRP Protocol

Initial Treatment Phase:

  • Perform 3-5 sessions spaced exactly one month apart. 1, 2
  • Use 5-7 mL of PRP per session at a rate of 0.05 to 0.1 mL/cm². 1
  • Inject at 90-degree angle, 2-4 mm depth, with injections 1 cm apart. 1
  • Use 30G × 4 mm needles to minimize discomfort. 1

Maintenance Phase:

  • Continue with 1 session every 6 months after completing initial treatment phase. 1, 2

Throughout Treatment:

  • Continue topical minoxidil 5% (1 mL) twice daily during and after PRP sessions. 1

Important Procedural Details

  • Apply pharmaceutical-grade topical anesthetic cream before injection due to significant pain. 1
  • Patient must shampoo and detangle hair before each session, with no hair products applied. 1
  • Use manual double-spin method for PRP preparation with platelet concentration of 1 to 1.5 million platelets per µL. 1
  • PRP activation is NOT required for androgenetic alopecia. 1

Alternative Advanced Option: Platelet-Rich Fibrin (PRF)

  • PRF represents a promising alternative to PRP with theoretical advantages including longer growth factor release and potentially lower cost. 2
  • PRF functions as both scaffold and reservoir for growth factors with prolonged release. 2
  • Liquid-PRF is safe, easy, time and cost-effective for managing androgenetic alopecia. 5
  • However, high-quality comparative studies are lacking, so PRP remains the better-evidenced choice. 2

Additional Treatment Option: Low-Level Laser Therapy (LLLT)

  • LLLT is FDA-cleared and demonstrates efficacy in female androgenetic alopecia. 1, 6
  • Recommended usage is three times per week. 1
  • Meta-analysis confirms LLLT is superior to placebo (P < .00001) for promoting hair growth. 3
  • Can be used as monotherapy or combined with minoxidil. 6

Monitoring Treatment Response

Evaluate treatment efficacy using multiple objective methods at regular intervals:

  • Standardized before-and-after photographs taken under identical lighting and positioning. 1, 2
  • Trichoscopy to evaluate hair density and diameter. 1, 2
  • Hair pull tests to evaluate hair fragility (should become negative after successful treatment). 2
  • Patient self-assessment questionnaires for subjective improvement. 1, 2

Key indicators of positive response include:

  • Increased hair density and shaft diameter. 2
  • Decreased proportion of telogen hairs. 2
  • Improved patient satisfaction scores. 2
  • Negative hair pull test after treatment (83% of patients in studies). 5

Evaluate treatment response after one year of combination therapy. 1

Critical Pitfalls to Avoid

  • Inadequate follow-up to assess treatment response leads to suboptimal outcomes. 1
  • Stopping minoxidil causes complete reversal of benefits—patients must understand this is lifelong therapy. 1
  • The efficacy of treatments decreases with the severity and duration of alopecia, so earlier intervention is better. 1
  • Using PRP without proper anesthesia causes significant pain and poor patient compliance. 1

Treatment Algorithm Summary

  1. All patients: Start topical minoxidil 5% twice daily indefinitely
  2. Inadequate response or desire for enhanced results: Add PRP therapy (3-5 monthly sessions, then maintenance every 6 months)
  3. Alternative/adjunctive option: LLLT three times per week
  4. Monitor response: Use photographs, trichoscopy, hair pull tests, and patient questionnaires at regular intervals

References

Guideline

Treatment Options for Female Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Androgenetic Alopecia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Minoxidil Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Physical Treatments and Therapies for Androgenetic Alopecia.

Journal of clinical medicine, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.